Comparison of two simulators for individual based models in HIV epidemiology in a population with HSV 2 in Yaoundé (Cameroon).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 07 2021
Historique:
received: 05 12 2020
accepted: 05 07 2021
entrez: 20 7 2021
pubmed: 21 7 2021
medline: 1 12 2021
Statut: epublish

Résumé

Model comparisons have been widely used to guide intervention strategies to control infectious diseases. Agreement between different models is crucial for providing robust evidence for policy-makers because differences in model properties can influence their predictions. In this study, we compared models implemented by two individual-based model simulators for HIV epidemiology in a heterosexual population with Herpes simplex virus type-2 (HSV-2). For each model simulator, we constructed four models, starting from a simplified basic model and stepwise including more model complexity. For the resulting eight models, the predictions of the impact of behavioural interventions on the HIV epidemic in Yaoundé-Cameroon were compared. The results show that differences in model assumptions and model complexity can influence the size of the predicted impact of the intervention, as well as the predicted qualitative behaviour of the HIV epidemic after the intervention. These differences in predictions of an intervention were also observed for two models that agreed in their predictions of the HIV epidemic in the absence of that intervention. Without additional data, it is impossible to determine which of these two models is the most reliable. These findings highlight the importance of making more data available for the calibration and validation of epidemiological models.

Identifiants

pubmed: 34282252
doi: 10.1038/s41598-021-94289-z
pii: 10.1038/s41598-021-94289-z
pmc: PMC8289823
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14696

Informations de copyright

© 2021. The Author(s).

Références

AIDS. 2001 Aug;15 Suppl 4:S97-108
pubmed: 11686471
PLoS One. 2009 Oct 07;4(10):e7365
pubmed: 19809510
PLoS One. 2016 Mar 01;11(3):e0150513
pubmed: 26930406
PLoS One. 2015 Jan 21;10(1):e114989
pubmed: 25608026
Epidemics. 2017 Mar;18:1-3
pubmed: 28279450
PLoS Med. 2013 Oct;10(10):e1001534
pubmed: 24167449
AIDS. 2001 Aug;15 Suppl 4:S61-9
pubmed: 11686467
Epidemics. 2018 Mar;22:13-21
pubmed: 28958414
AIDS. 2001 Aug;15 Suppl 4:S127-31
pubmed: 11686461
Vaccine. 2017 Oct 13;35(43):5835-5841
pubmed: 28941619
South Afr J HIV Med. 2018 Feb 21;19(1):756
pubmed: 29568647
Sex Transm Infect. 1999 Dec;75(6):377-84
pubmed: 10754939
J Chem Phys. 2007 Dec 7;127(21):214107
pubmed: 18067349
Euro Surveill. 2009 Nov 26;14(47):
pubmed: 19941804
PLoS One. 2010 Apr 01;5(4):e9936
pubmed: 20376191
PLoS One. 2018 Mar 19;13(3):e0194220
pubmed: 29554136
J Sex Res. 2019 Jan;56(1):1-8
pubmed: 30044926
AIDS. 2001 Aug;15 Suppl 4:S117-26
pubmed: 11686460
J Int AIDS Soc. 2013 Dec 02;16 Suppl 3:18752
pubmed: 24321114
PLoS Comput Biol. 2019 Nov 22;15(11):e1007486
pubmed: 31756193
Math Biosci. 2016 Dec;282:91-108
pubmed: 27712990
Sex Transm Infect. 2007 Aug;83 Suppl 1:i5-16
pubmed: 17405781
J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):175-183
pubmed: 28498144
BMC Med. 2019 Sep 9;17(1):172
pubmed: 31495336
PLoS Med. 2012;9(7):e1001245
pubmed: 22802730
BMC Infect Dis. 2017 Sep 11;17(1):612
pubmed: 28893198
Br Med Bull. 2001;58:155-70
pubmed: 11714629
Herpes. 2004 Apr;11 Suppl 1:24A-35A
pubmed: 15115627
AIDS. 2001 Aug;15 Suppl 4:S41-50
pubmed: 11686464
AIDS. 2001 Aug;15 Suppl 4:S5-14
pubmed: 11686465
Curr Opin HIV AIDS. 2010 Jul;5(4):305-10
pubmed: 20543605
PLoS One. 2017 Jan 31;12(1):e0170893
pubmed: 28141867
Clin Microbiol Infect. 2013 Nov;19(11):999-1005
pubmed: 24266045
Virus Evol. 2018 Nov 21;4(2):vey032
pubmed: 30483403
Sci Rep. 2019 Dec 17;9(1):19289
pubmed: 31848434
Lancet Glob Health. 2015 Oct;3(10):e598-608
pubmed: 26385301
PLoS Med. 2012 Jan;9(1):e1001157
pubmed: 22272189
Sex Transm Dis. 2016 Mar;43(3):139-46
pubmed: 26859800

Auteurs

Diana M Hendrickx (DM)

I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium. diana.hendrickx@uhasselt.be.

João Dinis Sousa (JD)

Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, KU Leuven, 3000, Leuven, Belgium.
Global Health and Tropical Medicine (GHTM), Unidade de Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.

Pieter J K Libin (PJK)

I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium.
Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, KU Leuven, 3000, Leuven, Belgium.
Artificial Intelligence Lab, Department of Computer Science, Vrije Universiteit Brussel, 1050, Brussels, Belgium.

Wim Delva (W)

I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium.
Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, KU Leuven, 3000, Leuven, Belgium.
The South African Department of Science and Technology-National Research Foundation (DST-NRF) Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
Department of Global Health, Faculty of Medicine and Health, Stellenbosch University, Stellenbosch, South Africa.
International Centre for Reproductive Health, Ghent University, Ghent, Belgium.
School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.

Jori Liesenborgs (J)

Expertise Centre for Digital Media, Hasselt University - tUL, Diepenbeek, Belgium.

Niel Hens (N)

I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium.
Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Viktor Müller (V)

Institute of Biology, Eötvös Loránd University, Budapest, Hungary.

Anne-Mieke Vandamme (AM)

Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, KU Leuven, 3000, Leuven, Belgium.
Global Health and Tropical Medicine (GHTM), Unidade de Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Department of Microbiology, Immunology and Transplantation, Institute for the Future, Rega Institute for Medical Research, KU Leuven, 3000, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH